{
  "success": true,
  "applicability": {
    "isApplicable": false,
    "reasons": [
      {
        "type": "condition",
        "description": "Patient does not have required condition: Premature coronary artery disease",
        "details": "The study required patients to have Premature coronary artery disease"
      },
      {
        "type": "biomarker",
        "description": "Missing biomarker data: lipoprotein(a)",
        "details": "The study results are based on lipoprotein(a) levels, which are not in the patient's records"
      }
    ]
  },
  "patientSummary": {
    "age": 42,
    "sex": "male",
    "relevantBiomarkers": [
      {
        "name": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "value": "55",
        "unit": "mg/dL",
        "date": "2023-03-07T16:18:17.000Z"
      },
      {
        "name": "Cholesterol [Mass/volume] in Serum or Plasma",
        "value": "182",
        "unit": "mg/dL",
        "date": "2023-03-07T16:18:17.000Z"
      },
      {
        "name": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay",
        "value": "110",
        "unit": "mg/dL",
        "date": "2023-03-07T16:18:17.000Z"
      },
      {
        "name": "Triglyceride [Mass/volume] in Serum or Plasma",
        "value": "85",
        "unit": "mg/dL",
        "date": "2023-03-07T16:18:17.000Z"
      }
    ],
    "relevantConditions": [],
    "relevantMedications": [
      "valACYclovir 500 MG Oral Tablet",
      "loratadine (CLARITIN) 10 mg tablet",
      "valACYclovir 500 MG Oral Tablet",
      "SUMAtriptan succinate 25 MG Oral Tablet",
      "ondansetron HCl 4 MG Oral Tablet",
      "rizatriptan benzoate 10 MG Oral Tablet",
      "valACYclovir 500 MG Oral Tablet",
      "amoxicillin 875 MG Oral Tablet",
      "levoFLOXacin 500 MG Oral Tablet",
      "Claritin",
      "Vitamin D",
      "Nurtec ODT 75 MG Disintegrating Oral Tablet",
      "Maxalt 10 MG Oral Tablet",
      "rimegepant 75 MG Disintegrating Oral Tablet",
      "valACYclovir 500 MG Oral Tablet",
      "loratadine 10 MG 24HR Oral Capsule",
      "levoFLOXacin 500 MG Oral Tablet",
      "valACYclovir 500 MG Oral Tablet"
    ]
  },
  "paperSummary": {
    "title": "Premature coronary artery disease in women: sex-specific risk factors, pathogenetic mechanisms and clinical implications",
    "intervention": "Aggressive lipid control, metabolic risk reduction, and psychosocial support",
    "primaryEndpoint": "Early detection and tailored treatment of female PCAD",
    "population": "Women with premature coronary artery disease (PCAD), defined as onset â‰¤65 years"
  }
}